Saakshi Medtech and Panels Limited
NSE: SAAKSHI · Unclassified
Ask the data
Instant answers about Saakshi Medtech and Panels Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY24 | FY25 | FY26 | |
|---|---|---|---|
| Revenue | 121.8 | 92.4 | 115.5 |
| EBITDA | 19.7 | 10.3 | 22.2 |
| Operating margin | 16.1% | 11.2% | 19.2% |
| Interest | 1.6 | 0.4 | 1.4 |
| Depreciation | 3.9 | 3.9 | 4.7 |
| Profit before tax | 14.9 | 6.6 | 16.7 |
| Tax | 3.6 | 1.8 | 4.4 |
| Net profit | 11.3 | 4.8 | 12.3 |
| EPS ₹ | 0.00 | 2.67 | 6.96 |
| Operating cash flow | 7.3 | 3.0 | 17.6 |
| Capex | 31.7 | 15.0 | 24.6 |
| Dividend paid | 0.0 | 0.0 | 0.0 |
| Total assets | — | 131.3 | 157.0 |
| Equity | — | 98.0 | 110.3 |
Half-yearly performance
last 6 half years · ₹ crore| H1 FY24* | H2 FY24 | H1 FY25 | H2 FY25 | H1 FY26 | H2 FY26 | |
|---|---|---|---|---|---|---|
| Revenue | 61.3 | 60.6 | 44.5 | 48.0 | 58.3 | 57.2 |
| Operating profit | 9.9 | 9.8 | 6.5 | 3.8 | 10.7 | 11.6 |
| Operating margin | 16.2% | 16.1% | 14.6% | 7.9% | 18.3% | 20.2% |
| Other income | 0.1 | 0.7 | 0.3 | 0.3 | 0.3 | 0.2 |
| Interest | 0.8 | 0.8 | 0.2 | 0.2 | 0.3 | 1.1 |
| Depreciation | 1.8 | 2.0 | 1.8 | 2.1 | 1.9 | 2.9 |
| Profit before tax | 7.3 | 7.6 | 4.8 | 1.8 | 8.8 | 7.8 |
| Tax | 1.7 | 2.0 | 1.2 | 0.6 | 2.2 | 2.2 |
| Net profit | 5.7 | 5.7 | 3.5 | 1.3 | 6.6 | 5.7 |
| EPS ₹ | 0.00 | 0.00 | 1.96 | 0.71 | 0.00 | 3.21 |
| Revenue YoY | — | — | -27.4% | -20.8% | 31.2% | 19.2% |
| Profit YoY | — | — | -39.0% | -77.7% | 92.2% | 349.2% |
Returns & margins
trailing-twelve-month, per half year| H2 FY24 | H1 FY25 | H2 FY25 | H1 FY26 | H2 FY26 | |
|---|---|---|---|---|---|
| ROE | — | 9.4% | 4.8% | 7.5% | 11.1% |
| ROCE | — | 12.1% | 6.0% | 8.6% | 13.3% |
| Net margin | 9.3% | 8.7% | 5.1% | 7.4% | 10.6% |
| EBITDA margin | 16.1% | 15.5% | 11.2% | 13.6% | 19.2% |
| Debt / equity | — | 0.14 | 0.18 | 0.23 | 0.23 |
| Interest coverage | 10.17 | 13.41 | 17.07 | 24.67 | 13.35 |
| Asset turnover | — | 0.82 | 0.70 | 0.72 | 0.74 |
Balance sheet
equity vs borrowings over time · ₹ crore| SEP '24 | MAR '25 | SEP '25 | MAR '26 | |
|---|---|---|---|---|
| Share capital | 17.7 | 17.7 | 17.7 | 17.7 |
| Other equity / reserves | 79.1 | 80.4 | 87.0 | 92.7 |
| Total equity | 96.8 | 98.0 | 104.7 | 110.3 |
| Borrowings | 14.0 | 17.8 | 23.9 | 25.4 |
| Current liabilities | 17.9 | 18.6 | 25.6 | 29.8 |
| Non-current liabilities | 12.8 | 14.7 | 17.4 | 16.8 |
| Total assets | 127.5 | 131.3 | 147.6 | 157.0 |
| Property, plant & equipment | 60.7 | 59.4 | 75.1 | 83.0 |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventories | 23.3 | 20.4 | 24.9 | 21.4 |
| Receivables | 15.8 | 21.9 | 23.7 | 26.2 |
| Cash & equivalents | 10.2 | 3.3 | 1.6 | 1.8 |
Cash flow
annual · ₹ crore · line = free cash flow| FY24 | FY25 | FY26 | |
|---|---|---|---|
| Cash from operations | 7.3 | 3.0 | 17.6 |
| Cash from investing | -31.1 | -14.7 | -25.3 |
| Cash from financing | 36.1 | -0.6 | 6.3 |
| Capex | 31.7 | 15.0 | 24.6 |
| Free cash flow | -24.4 | -12.0 | -7.0 |
| Dividends paid | 0.0 | 0.0 | 0.0 |
Where the assets sit
Mar '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Saakshi Medtech and Panels Limited | 657 | 372.00 | 53.4 | 5.95 | 11.1% |
StoxGud checklist: Bullish setup · 8/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Saakshi Medtech and Panels Limited?
Saakshi Medtech and Panels Limited (SAAKSHI) closed at ₹372.00 on NSE on 06 Nov 2026.
What is the market cap of Saakshi Medtech and Panels Limited?
₹657 crore at the latest close.
What is the P/E ratio of Saakshi Medtech and Panels Limited?
53.4, on trailing-twelve-month earnings from its filings.
How fast is Saakshi Medtech and Panels Limited growing?
Saakshi Medtech and Panels Limited: Latest-half-year revenue is up 19.2% year on year, profit up 349.2%.
How profitable is Saakshi Medtech and Panels Limited?
On a trailing-twelve-month basis return on equity is 11.1%, return on capital employed 13.3%, operating margin 19.2%, net margin 10.6%.
How much debt does Saakshi Medtech and Panels Limited have?
Saakshi Medtech and Panels Limited is lightly geared: debt to equity is 0.23 with borrowings of ₹25 cr against cash of ₹2 cr (balance sheet of 2026-03-31). Operating profit covers interest 13.3 times.
Financials parsed from Saakshi Medtech and Panels Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Half-yearly from H1 FY24, annual from FY24, balance sheet from Sep '24. * = derived (full year minus the other half). This company is on NSE's SME platform and reports results half-yearly. Information only, not investment advice.